Question 1

What are the potential side effects of DONQ52?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatments for celiac disease?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the study involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my current treatment for celiac disease change if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients clinical trial (NCT05425446). Contact the study team or your healthcare provider for specific answers.

What this study is about